nifedipine has been researched along with Adenoma in 11 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, we have studied the acute and chronic effect of nifedipine in 7 patients with idiopathic hyperaldosteronism (IHA) and 8 with aldosterone producing adenoma (APA)." | 9.06 | Acute and chronic effect of nifedipine in primary aldosteronism. ( Carpenè, G; Mantero, F; Opocher, G; Rocco, S, 1989) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 5.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| " Therefore, we have studied the acute and chronic effect of nifedipine in 7 patients with idiopathic hyperaldosteronism (IHA) and 8 with aldosterone producing adenoma (APA)." | 5.06 | Acute and chronic effect of nifedipine in primary aldosteronism. ( Carpenè, G; Mantero, F; Opocher, G; Rocco, S, 1989) |
| "To determine the potential therapeutic effect of calcium entry blockade in primary aldosteronism, 10 patients (5 adenoma and 5 hyperplasia) documented by endocrine testing and/or surgery were given nifedipine (20 mg, sublingually) in the afternoon." | 3.67 | Therapeutic effect of calcium channel blockade in primary aldosteronism. ( Horton, R; Hsueh, W; Nadler, JL, 1985) |
| "Results suggest that, in parathyroid adenoma cells, regulation of PTH secretion with respect to intracellular calcium concentration would be maintained despite differing response of intracellular calcium concentration following exposure to calcium-entry blockers." | 1.30 | In vivo effects of calcium entry blockers on human parathyroid adenoma cells with special reference to calcium sensing ability and the hormone secretion. ( Hanafusa, T; Horikawa, Y; Iizuka, K; Imagawa, A; Kuwajima, M; Matsuzawa, Y; Miyagawa, J; Nakajima, H; Namba, M; Shiba, E; Takai, S; Tomita, K, 1999) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 1.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, U | 1 |
| Klein, B | 1 |
| Klehr, HU | 1 |
| Yin, J | 2 |
| Deng, J | 2 |
| Shi, Y | 2 |
| Shu, C | 1 |
| Motoyoshi, S | 1 |
| Shirotani, T | 1 |
| Araki, E | 1 |
| Sakai, K | 1 |
| Kaneko, K | 1 |
| Motoshima, H | 1 |
| Yoshizato, K | 1 |
| Shirakami, A | 1 |
| Kishikawa, H | 1 |
| Shichiri, M | 1 |
| Horikawa, Y | 1 |
| Nakajima, H | 1 |
| Iizuka, K | 1 |
| Imagawa, A | 1 |
| Tomita, K | 1 |
| Shiba, E | 1 |
| Takai, S | 1 |
| Miyagawa, J | 1 |
| Kuwajima, M | 1 |
| Namba, M | 1 |
| Hanafusa, T | 1 |
| Matsuzawa, Y | 1 |
| Cely, CM | 1 |
| Contreras, G | 1 |
| Lo, YK | 1 |
| Wu, SN | 1 |
| Lee, CT | 1 |
| Li, HF | 1 |
| Chiang, HT | 1 |
| Al Saad, KO | 1 |
| Chan, NH | 1 |
| Demura, R | 1 |
| Naruse, M | 1 |
| Isawa, M | 1 |
| Onoda, N | 1 |
| Naruse, K | 1 |
| Yamakado, M | 1 |
| Demura, H | 1 |
| Carpenè, G | 1 |
| Rocco, S | 1 |
| Opocher, G | 1 |
| Mantero, F | 1 |
| Nadler, JL | 1 |
| Hsueh, W | 1 |
| Horton, R | 1 |
1 trial available for nifedipine and Adenoma
| Article | Year |
|---|---|
Acute and chronic effect of nifedipine in primary aldosteronism.
Topics: Adenoma; Aldosterone; Antihypertensive Agents; Blood Pressure; Humans; Hyperaldosteronism; Nifedipin | 1989 |
10 other studies available for nifedipine and Adenoma
| Article | Year |
|---|---|
Cumulative side effects of cyclosporine and Ca antagonists: hypergalactinemia, mastadenoma, and gynecomastia.
Topics: Adenoma; Adult; Aged; Breast Neoplasms, Male; Calcium Channel Blockers; Cyclosporine; Diltiazem; Dru | 1994 |
[The role of Ca2+ in the pathogenesis of human pituitary GH-secreting adenomas].
Topics: Adenoma; Biological Transport, Active; Calcimycin; Calcium; Calcium Channel Blockers; Growth Hormone | 1996 |
The role of calcium ion in the pathogenesis of human pituitary GH-secreting adenomas.
Topics: Adenoma; Biological Transport, Active; Calcium; Calcium Channel Blockers; Growth Hormone; Growth Hor | 1996 |
Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.
Topics: Adenoma; Calcium Channel Blockers; Corticotropin-Releasing Hormone; Diazoxide; Gene Expression; Gluc | 1998 |
In vivo effects of calcium entry blockers on human parathyroid adenoma cells with special reference to calcium sensing ability and the hormone secretion.
Topics: Adenoma; Calcium; Calcium Channel Blockers; Humans; Microscopy, Confocal; Microscopy, Fluorescence; | 1999 |
Approach to the patient with hypertension, unexplained hypokalemia, and metabolic alkalosis.
Topics: Adenoma; Adrenalectomy; Aldosterone; Alkalosis; Antihypertensive Agents; Diagnosis, Differential; Hu | 2001 |
Characterization of action potential waveform-evoked L-type calcium currents in pituitary GH3 cells.
Topics: Action Potentials; Adenoma; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Da | 2001 |
Test and teach. Surgically correctable hypertension. Conn's syndrome and spironolactone bodies.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2001 |
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoc | 1992 |
Therapeutic effect of calcium channel blockade in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Aldosterone; Blood Pressure; Female; Humans; Hyperal | 1985 |